Literature DB >> 23975172

Audit of the informed consent process as a part of a clinical research quality assurance program.

Pramod M Lad1, Rebecca Dahl.   

Abstract

Audits of the informed consent process are a key element of a clinical research quality assurance program. A systematic approach to such audits has not been described in the literature. In this paper we describe two components of the audit. The first is the audit of the informed consent document to verify adherence with federal regulations. The second component is comprised of the audit of the informed consent conference, with emphasis on a real time review of the appropriate communication of the key elements of the informed consent. Quality measures may include preparation of an informed consent history log, notes to accompany the informed consent, the use of an informed consent feedback tool, and the use of institutional surveys to assess comprehension of the informed consent process.

Mesh:

Year:  2013        PMID: 23975172     DOI: 10.1007/s11948-013-9461-4

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  21 in total

1.  Policies and quality assurance in the pharmaceutical industry.

Authors:  Adil E Shamoo
Journal:  Account Res       Date:  1991       Impact factor: 2.622

2.  Numerous violations of federal informed consent requirements.

Authors:  Dennis M Maloney
Journal:  Hum Res Rep       Date:  2004-01

3.  Is patients' time too valuable for informed consent?

Authors:  Arthur R Derse
Journal:  Am J Bioeth       Date:  2007-12       Impact factor: 11.229

4.  Beyond informed consent: the therapeutic misconception and trust.

Authors:  I de Melo-Martín; A Ho
Journal:  J Med Ethics       Date:  2008-03       Impact factor: 2.903

5.  Recall of informed consent information by healthy volunteers in clinical trials.

Authors:  P Fortun; J West; L Chalkley; A Shonde; C Hawkey
Journal:  QJM       Date:  2008-05-16

6.  An institutional review board-based clinical research quality assurance program.

Authors:  Pramod M Lad; Rebecca Dahl
Journal:  Account Res       Date:  2013       Impact factor: 2.622

7.  Quality of informed consent: measuring understanding among participants in oncology clinical trials.

Authors:  Roseann Barrett
Journal:  Oncol Nurs Forum       Date:  2005-07-01       Impact factor: 2.172

8.  Quality of informed consent: a new measure of understanding among research subjects.

Authors:  S Joffe; E F Cook; P D Cleary; J W Clark; J C Weeks
Journal:  J Natl Cancer Inst       Date:  2001-01-17       Impact factor: 13.506

9.  Improving comprehension of informed consent.

Authors:  Sanja Kusec; Stipe Oresković; Mate Skegro; Dragan Korolija; Zeljko Busić; Matija Horzić
Journal:  Patient Educ Couns       Date:  2006-01-20

Review 10.  Improvement of informed consent and the quality of consent documents.

Authors:  Michael Jefford; Rosemary Moore
Journal:  Lancet Oncol       Date:  2008-05       Impact factor: 41.316

View more
  3 in total

Review 1.  Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis.

Authors:  Nguyen Thanh Tam; Nguyen Tien Huy; Le Thi Bich Thoa; Nguyen Phuoc Long; Nguyen Thi Huyen Trang; Kenji Hirayama; Juntra Karbwang
Journal:  Bull World Health Organ       Date:  2015-01-22       Impact factor: 9.408

2.  Application of the rapid ethical assessment approach to enhance the ethical conduct of longitudinal population based female cancer research in an urban setting in Ethiopia.

Authors:  Alem Gebremariam; Alemayehu Worku Yalew; Selamawit Hirpa; Abigiya Wondimagegnehu; Mirgissa Kaba; Mathewos Assefa; Israel Mitiku; Eva Johanna Kantelhardt; Ahmedin Jemal; Adamu Addissie
Journal:  BMC Med Ethics       Date:  2018-11-14       Impact factor: 2.652

Review 3.  Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review.

Authors:  William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Journal:  Clin Trials       Date:  2021-02-20       Impact factor: 2.486

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.